Literature DB >> 23855509

Goto-Kakizaki rats: its suitability as non-obese diabetic animal model for spontaneous type 2 diabetes mellitus.

Muhammad Sajid Akash1, Kanwal Rehman, Shuqing Chen.   

Abstract

β-cell dysfunction and apoptosis are recognized as a major cause of insufficient insulin secretion in response to high blood glucose and metabolic demand. As a consequence, type 2 diabetes mellitus (T2DM) is known to occur. Taking into account the etiology of T2DM, to conduct investigational studies directly on human diabetic patients seems to be unsuitable; thereby, various animal models have been established to investigate the pathogenesis of T2DM. Among these models, Goto-Kakizaki (GK) rats have been considered as one of the best non-obese type 2 diabetic animal model. GK rats exhibit valuable characteristic tools that are more or less common and functionally present in human diabetic patients. This animal model is considered appropriate to inspect various pathologic mechanisms of T2DM. Thereby, in our present article, we have comprehensively summarized the information relating the characteristics of abnormalities including a description of assorted mechanisms involved in pathogenesis of T2DM in GK rats. This might help to investigate various aspects of spontaneous T2DM.

Entities:  

Mesh:

Year:  2013        PMID: 23855509     DOI: 10.2174/15733998113099990069

Source DB:  PubMed          Journal:  Curr Diabetes Rev        ISSN: 1573-3998


  36 in total

1.  Effect and mechanisms of zinc supplementation in protecting against diabetic cardiomyopathy in a rat model of type 2 diabetes.

Authors:  Ying Lu; Ya Liu; Hongyan Li; Xue Wang; Wenjie Wu; Lichao Gao
Journal:  Bosn J Basic Med Sci       Date:  2015-02-05       Impact factor: 3.363

2.  Neurolytic celiac plexus block enhances skeletal muscle insulin signaling and attenuates insulin resistance in GK rats.

Authors:  Jun Li; Tao Chen; Kun Li; Hongtao Yan; Xiaowei Li; Yun Yang; Yulan Zhang; Bingyin Su; Fuxiang Li
Journal:  Exp Ther Med       Date:  2016-02-19       Impact factor: 2.447

3.  Type 2 diabetes alters bone and marrow blood flow and vascular control mechanisms in the ZDF rat.

Authors:  John N Stabley; Rhonda D Prisby; Bradley J Behnke; Michael D Delp
Journal:  J Endocrinol       Date:  2015-04       Impact factor: 4.286

4.  Skeletal muscle energetics are compromised only during high-intensity contractions in the Goto-Kakizaki rat model of type 2 diabetes.

Authors:  Matthew T Lewis; Jonathan D Kasper; Jason N Bazil; Jefferson C Frisbee; Robert W Wiseman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-06-12       Impact factor: 3.619

5.  SHR3824, a novel selective inhibitor of renal sodium glucose cotransporter 2, exhibits antidiabetic efficacy in rodent models.

Authors:  Pang-ke Yan; Li-na Zhang; Ying Feng; Hui Qu; Li Qin; Lian-shan Zhang; Ying Leng
Journal:  Acta Pharmacol Sin       Date:  2014-05       Impact factor: 6.150

6.  Linagliptin reduces effects of ET-1 and TLR2-mediated cerebrovascular hyperreactivity in diabetes.

Authors:  Trevor Hardigan; Yasir Abdul; Adviye Ergul
Journal:  Life Sci       Date:  2016-02-17       Impact factor: 5.037

7.  Influence of New Modified Biliopancreatic Diversion on Blood Glucose and Lipids in GK rats.

Authors:  Shangeng Weng; Bin Zhang; Changguo Xu; Su Feng; Hongxing He
Journal:  Obes Surg       Date:  2017-03       Impact factor: 4.129

8.  A Comparative Study of the Effect of Gastric Bypass, Sleeve Gastrectomy, and Duodenal-Jejunal Bypass on Type-2 Diabetes in non-Obese Rats.

Authors:  Bo Xu; Xiaojie Yan; Yikai Shao; Qiwei Shen; Rong Hua; Rui Ding; Qiyuan Yao
Journal:  Obes Surg       Date:  2015-10       Impact factor: 4.129

Review 9.  Alternatives to the Streptozotocin-Diabetic Rodent.

Authors:  M A Yorek
Journal:  Int Rev Neurobiol       Date:  2016-03-28       Impact factor: 3.230

10.  Is a Simple Food-Diverting Operation the Solution for Type 2 Diabetes Treatment? Experimental Study in a Non-Obese Rat Model.

Authors:  John Melissas; Drakos Peirasmakis; Vasileios Lamprou; John Papadakis
Journal:  Obes Surg       Date:  2016-05       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.